HomeCompareGEBHY vs MRK

GEBHY vs MRK: Dividend Comparison 2026

GEBHY yields 1.77% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.8K in total portfolio value
10 years
GEBHY
GEBHY
● Live price
1.77%
Share price
$2.90
Annual div
$0.05
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$0.18
Full GEBHY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GEBHY vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGEBHYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GEBHY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GEBHY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GEBHY
Annual income on $10K today (after 15% tax)
$150.77/yr
After 10yr DRIP, annual income (after tax)
$0.15/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,328.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GEBHY + MRK for your $10,000?

GEBHY: 50%MRK: 50%
100% MRK50/50100% GEBHY
Portfolio after 10yr
$38.4K
Annual income
$4,899.16/yr
Blended yield
12.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GEBHY
No analyst data
Altman Z
1.1
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GEBHY buys
0
MRK buys
0
No recent congressional trades found for GEBHY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGEBHYMRK
Forward yield1.77%2.76%
Annual dividend / share$0.05$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$20.0K$56.8K
Annual income after 10y$0.18$9,798.13
Total dividends collected$178.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GEBHY vs MRK ($10,000, DRIP)

YearGEBHY PortfolioGEBHY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,789$88.69$11,206$366.19$417.00MRK
2$11,589$44.71$12,650$502.35$1.1KMRK
3$12,422$22.44$14,407$694.19$2.0KMRK
4$13,303$11.24$16,585$967.82$3.3KMRK
5$14,240$5.63$19,342$1,363.89$5.1KMRK
6$15,240$2.81$22,913$1,947.19$7.7KMRK
7$16,308$1.41$27,662$2,823.89$11.4KMRK
8$17,450$0.70$34,159$4,173.35$16.7KMRK
9$18,672$0.35$43,337$6,308.80$24.7KMRK
10$19,979$0.18$56,776$9,798.13$36.8KMRK

GEBHY vs MRK: Complete Analysis 2026

GEBHYStock

Genting Berhad, an investment holding company, engages in leisure and hospitality, oil palm plantation, power generation, oil and gas, property development and management, life sciences, and biotechnology businesses in Malaysia and internationally. Its Leisure & Hospitality segment is involved in gaming, hotels, food and beverages, theme parks, retail, entertainment and attractions, and tours and travel related businesses; the development and operation of resorts; and the provision of other support services. The company's Plantation segment operates oil palm plantations, and palm oil milling and related activities. Its Power segment generates and supplies electric power. The company's Property segment develops and invests in properties. Its Oil & Gas segment explores for, develops, and produces oil and gas. The company also offers offshore financing; advisory, technical, and administrative services to oil and gas companies; and risk and insurance management consultancy services, as well as issues private debt securities and licenses intellectual property rights. In addition, it manufactures and sells biodiesel; processes fresh fruit bunches; provides project management, technical, and other management services; and researches and develops technologies for genetic analysis and sequencing. Further, it creates platform for early diagnosis and treatment of Alzheimer's and other neurodegenerative diseases; and undertakes the collection, analysis, and testing of specimens, samples, and/or data for research and evaluation activities. Additionally, it engages in the provision of information technology services relating to the gaming and resort industry; and provision of international sales and marketing services, and corporate services. Genting Berhad was founded in 1965 and is headquartered in Kuala Lumpur, Malaysia.

Full GEBHY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GEBHY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GEBHY vs SCHDGEBHY vs JEPIGEBHY vs OGEBHY vs KOGEBHY vs MAINGEBHY vs JNJGEBHY vs ABBVGEBHY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.